Advertisement
DIA
Drug Information Association Logo

Meetings & Training

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations.

Find Meetings & Training 

Name Start Date Credits Format Region Location
Introduction to Signal Detection and Data Mining Sep 29, 2014 IACET Online Instruction Global Online
The Use of Mobile Medical Applications as Companions Oct 01, 2014 Online Instruction Global Online
Generic Drug Labeling Proposed Rule and Safety Updates Oct 01, 2014 Online Instruction Global Online
Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Oct 01, 2014 Online Instruction Global Online
Big Data: Impact of Health Care Reform on Collaborations and Strategies Oct 01, 2014 Online Instruction Global Online
Implementation of the FDASIA Patient Provisions Oct 01, 2014 Online Instruction Global Online
Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Oct 01, 2014 Online Instruction Global Online
Variations in the European Union: CMC/Quality Changes Oct 01, 2014 Online Instruction Global Online
Good Pharmacovigilance Practice: How Good has it Proven to be for Industry? Oct 01, 2014 Online Instruction Global Online
Pharmacovigilance and Risk Management: Patient Perspective Oct 01, 2014 Online Instruction Global Online
Complimentary Patient-Centeredness and Engagement in Clinical Research: Opportunities for Industry Oct 01, 2014 Online Instruction Global Online
Drug Safety Regulatory Requirements Oct 01, 2014 ACPE, IACET Online Instruction Global Online
Premarketing Clinical Trial Safety Oct 01, 2014 ACPE, IACET Online Instruction Global Online
Postmarketing Safety Management Oct 01, 2014 ACPE, IACET Online Instruction Global Online
Basics of Signal Detection and Pharmacoepidemiology Oct 01, 2014 ACPE, IACET Online Instruction Global Online
Safety Audits and Inspections Oct 01, 2014 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Oct 01, 2014 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Oct 01, 2014 Online Instruction Global Online
Pharmacovigilance and Global Harmonization Updates Oct 01, 2014 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Oct 01, 2014 Online Instruction Global Online
Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Oct 01, 2014 Online Instruction Global Online
Negotiation and Influence Oct 01, 2014 Online Instruction Global Online
China Update: Regulatory Changes and Implications Oct 01, 2014 Online Instruction Global Online
Evaluation and Management of Cardiac Conditions in Oncology Patients Oct 01, 2014 Online Instruction Global Online
Introduction to Drug Safety Oct 01, 2014 ACPE, IACET Online Instruction Global Online
How to Prepare for a Safety Inspection Oct 01, 2014 Online Instruction Global Online
Clinical Statistics for Nonstatisticians Oct 01, 2014 Online Instruction Global Online
Advanced Clinical Statistics for Nonstatisticians Oct 01, 2014 Online Instruction Global Online
Development of a Clinical Study Report Oct 01, 2014 Online Instruction Global Online
Art of Writing a Clinical Overview Oct 01, 2014 Online Instruction Global Online
CardioVascular Safety: The New Paradigm - Proarrhythmic Assessment of New Drugs without the Thorough QT Study Oct 01, 2014 Online Instruction Global Online
CardioVascular Safety – What are the Key Issues Regarding Blood Pressure Assessment During Clinical Development Oct 01, 2014 Online Instruction Global Online
Introductory Principles and Application of Risk Management within Clinical Operations Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part VI: Preclinical Toxicology & Safety Oct 01, 2014 Online Instruction Global Online
Electronic Submissions 101 – Essential MS Word and Adobe Acrobat Tools/Skills and Current IT Options Oct 01, 2014 Online Instruction Global Online
A Tour of FDA Oct 01, 2014 Online Instruction Global Online
A Tour of Health Canada Oct 01, 2014 Online Instruction Global Online
A Tour of Health Europe Oct 01, 2014 Online Instruction Global Online
Aspects of Regulatory History Oct 01, 2014 Online Instruction Global Online
Bioresearch Monitoring Program (BIMO): Introduction Oct 01, 2014 Online Instruction Global Online
The Clinical Development Process: Investigational Product, Plan, and Data Management Oct 01, 2014 Online Instruction Global Online
Drug Safety & Adverse Event Reporting Oct 01, 2014 Online Instruction Global Online
Ethical Review Boards Oct 01, 2014 Online Instruction Global Online
Ethics as the Foundation to Clinical Research Oct 01, 2014 Online Instruction Global Online
Awareness of FDA Inspections for Pharmaceutical Manufacturers Oct 01, 2014 Online Instruction Global Online
Biotechnology: An Overview of Compliance Considerations Oct 01, 2014 Online Instruction Global Online
Change Control Oct 01, 2014 Online Instruction Global Online
Clinical Trial Audits and Consequences of Non-Compliance Oct 01, 2014 Online Instruction Global Online
Computerized Systems Inspections in the Medical Device Industry Oct 01, 2014 Online Instruction Global Online
European Union Clinical Trials Directive Oct 01, 2014 Online Instruction Global Online
GMP Principals of SOPs Oct 01, 2014 Online Instruction Global Online
GMP Updates - Enforcement Changes at the New FDA Oct 01, 2014 Online Instruction Global Online
GMPs for API Bulk Manufacturers Oct 01, 2014 Online Instruction Global Online
Good Clinical Practices (GCPs) for New Product Investigations Oct 01, 2014 Online Instruction Global Online
Good Laboratory Practices (GLPs) Oct 01, 2014 Online Instruction Global Online
GxPs Oct 01, 2014 Online Instruction Global Online
HIPAA - The Impact on Clinical Research Oct 01, 2014 Online Instruction Global Online
Introduction to GMPs Oct 01, 2014 Online Instruction Global Online
Investigational Product Development Oct 01, 2014 Online Instruction Global Online
ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Oct 01, 2014 Online Instruction Global Online
Key Concepts of Process Validation Oct 01, 2014 Online Instruction Global Online
Laboratory Specimens for Clinical Research Oct 01, 2014 Online Instruction Global Online
Medical Device Safety Reporting Oct 01, 2014 Online Instruction Global Online
Orientation to GMP Compliance Oct 01, 2014 Online Instruction Global Online
Overview of the Clinical Research Process Oct 01, 2014 Online Instruction Global Online
Part 11: Electronic Records and Signatures - Application Oct 01, 2014 Online Instruction Global Online
Part 11: Electronic Records; Electronic Signatures Oct 01, 2014 Online Instruction Global Online
Principles of Good Documentation Oct 01, 2014 Online Instruction Global Online
Protection of Human Subjects in Clinical Trials Oct 01, 2014 Online Instruction Global Online
Selecting and Managing Clinical Contract Research Organizations (CROs) Oct 01, 2014 Online Instruction Global Online
Understanding Post-Approval Changes Oct 01, 2014 Online Instruction Global Online
Computerized Systems Inspections in the Pharmaceutical Industry Oct 01, 2014 Online Instruction Global Online
Basics of the PhRMA Code Oct 01, 2014 Online Instruction Global Online
Basics of AdvaMed Code Oct 01, 2014 Online Instruction Global Online
Eucomed Guidelines on Interactions with Healthcare Professionals Oct 01, 2014 Online Instruction Global Online
Introduction to Medical Device Health Care Compliance Oct 01, 2014 Online Instruction Global Online
Foreign Corrupt Practices Act Oct 01, 2014 Online Instruction Global Online
Global Anti-bribery Oct 01, 2014 Online Instruction Global Online
Variations to Marketing Authorisation in Europe Oct 01, 2014 Online Instruction Global Online
Registration of Monoclonal Antibodies Oct 01, 2014 Online Instruction Global Online
How to Gain Approval to Market a Generic Medicinal Product in the USA Oct 01, 2014 Online Instruction Global Online
Pharmacokinetics and Pharmacodynamics in Drug Registration Oct 01, 2014 Online Instruction Global Online
Complimentary - Planning and Implementing Large Cardiovascular Outcomes Studies: Opportunities & Challenges Oct 01, 2014 Online Instruction Global Online
Complimentary - Press the Easy Button – Ensure Consistency and Compliance for your Documents through Automation Oct 01, 2014 Online Instruction Global Online
Complimentary - When Outsourcing Stops Making Sense Oct 01, 2014 Online Instruction Global Online
Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Oct 01, 2014 Online Instruction Global Online
Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Oct 01, 2014 Online Instruction Global Online
Fundamentals of Project Management for Nonproject Managers Oct 01, 2014 Online Instruction Global Online
Planning and Managing Your Projects Oct 01, 2014 Online Instruction Global Online
Project Risk Management: Dealing with the Certainty of Uncertainty Oct 01, 2014 Online Instruction Global Online
Team Building and Development Oct 01, 2014 Online Instruction Global Online
Preparing a Clinical Trial Budget Oct 01, 2014 Online Instruction Global Online
Team Building and Development Oct 01, 2014 Online Instruction Global Online
Introduction to the European Union Institutions and Regulatory Authority Oct 01, 2014 Online Instruction Global Online
Introduction to US Institutions and Regulatory Authority (FDA) Oct 01, 2014 Online Instruction Global Online
Introduction to Japanese Institutions and Regulatory Authorities Oct 01, 2014 Online Instruction Global Online
Overview of the CTD and eCTD Oct 01, 2014 Online Instruction Global Online
Introduction to the International Conference on Harmonisation (ICH) Oct 01, 2014 Online Instruction Global Online
The Regulatory Development of a Drug Oct 01, 2014 Online Instruction Global Online
Basics of Clinical Trials Oct 01, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Centralized Procedure Oct 01, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Mutual Recognition Procedure Oct 01, 2014 Online Instruction Global Online
How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Oct 01, 2014 Online Instruction Global Online
How to Register a New Drug in the USA Oct 01, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Decentralized Procedure Oct 01, 2014 Online Instruction Global Online
Access to Unapproved Drugs through Compassionate Use Oct 01, 2014 Online Instruction Global Online
Regulatory Requirements for the Conduct of Clinical Trials in Europe Oct 01, 2014 Online Instruction Global Online
Orphan Drugs in the USA, European Union, and Japan Oct 01, 2014 Online Instruction Global Online
Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Oct 01, 2014 Online Instruction Global Online
Meeting Opportunities with Regulatory Agencies Oct 01, 2014 Online Instruction Global Online
Combination Products and Convergence: An Overview of Clinical Benefits, Regulatory Issues & Manufacturing Challenges Oct 01, 2014 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Oct 01, 2014 Online Instruction Global Online
Strategies for Successfully Introducing REMS to Your Organization: From Development and Implementation and Internal and External Evaluation Oct 01, 2014 Online Instruction Global Online
The Case of the New England Compounding Center: Learning from the Tragedy Oct 01, 2014 Online Instruction Global Online
Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Oct 01, 2014 Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Postmarketing Oct 01, 2014 Online Instruction Global Online
Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Oct 01, 2014 Online Instruction Global Online
The Future of Personalized Medicine and Companion Diagnostics Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Oct 01, 2014 Online Instruction Global Online
Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 2 Regulatory Framework US Overview Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Oct 01, 2014 Online Instruction Global Online
Basics of the IND Oct 01, 2014 Online Instruction Global Online
Basics of the NDA Oct 01, 2014 Online Instruction Global Online
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Oct 01, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part VII: Operational Challenges of Pediatric Clinical Trials Oct 01, 2014 Online Instruction Global Online
Supplements and Other Changes to an Approved Application Oct 01, 2014 Online Instruction Global Online
Disruptive Innovation in Medical Information Oct 06, 2014 ACPE, IACET Online Instruction Global Online
The Role of the Clinical Data Manager Oct 08, 2014 IACET Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Oct 09, 2014 ACPE, IACET Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part VII: Operational Challenges of Pediatric Clinical Trials Oct 14, 2014 ACPE, IACET Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Oct 21, 2014 IACET Online Instruction Global Online
Complimentary - Regulatory Solutions in the Cloud – 10 Questions You Can’t Afford NOT to Ask Oct 22, 2014 Online Instruction Global Online
How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Oct 28, 2014 Online Instruction Global Online
Negotiation and Influence Oct 30, 2014 IACET, PMI Online Instruction Global Online
Laboratory-developed Tests (LDTs) Oct 30, 2014 In-Person Instruction Global Washington, DC, United States
Quantitative Science Forum Oct 31, 2014 Meetings China Beijing, China
Cardio-Oncology: Innovative strategies for mitigating cardiovascular risk of new cancer therapies Nov 04, 2014 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Nov 06, 2014 ACPE, IACET Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 3 - Understanding the Legislation Landscape: Regulatory Updates from the FDA and EMA Nov 12, 2014 IACET Online Instruction Global Online
Proarrhythmia Nov 19, 2014 ACPE, IACET Online Instruction Global Online
Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Nov 20, 2014 ACPE, IACET Online Instruction Global Online
The 1st DIA China Drug Induced Cardiovascular Toxicity Workshop Nov 23, 2014 Meetings China
Preparation of a Successful (CTD) with Quality by Design (QbD) Dec 08, 2014 In-Person Instruction China
Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Dec 09, 2014 Online Instruction Global Online
FDA IND/NDA Workshop Dec 11, 2014 Meetings China Beijing, China
7th DIA China Annual Meeting May 24, 2015 Meetings China Shanghai, China